Login for faster access to the best deals. Click here if you don't have an account.

Great opportunity in multiple departments at Bharat Biotech

1 year ago   Medical & Healthcare   Hyderabad   108 views Reference: 33228
Job Details

Departments:

Bharat Biotech International Limited is hiring experienced professionals for various departments. Candidates with experience in the field of bioprocess, formulation and filling, quality control, quality assurance, packing, and visual inspection may find this an exciting opportunity to work with a leading biotechnology company.

Experience: The company is looking for candidates with 1 to 20 years of experience for various roles in their production, quality control, quality assurance, packing, and visual inspection departments.

Salary: The salary for these positions is negotiable, which means that it will be determined based on the candidate’s experience and qualifications.

Job Location: Hyderabad, India

Note: Kindly note the interested candidates can apply for the operator and junior technician positions at Bharat Biotech International Limited by either emailing their updated resume to “ [***] ” or by sending it via WhatsApp to the number

.For more articles, Kindly Click here.

For pharmaceutical jobs, follow us on LinkedIn

For more jobs, kindly visit our job section.

Company Description
Bharat Biotech International Limited (BBIL) is an Indian biotechnology company founded in 1996 by Dr. Krishna Ella. The company has a strong focus on research and development and has made significant contributions to the field of vaccines and biotherapeutics. BBILs state-of-the-art manufacturing facility is located in Hyderabad, India and is known for its cutting-edge technology and high production capacity. The companys portfolio of products includes vaccines for diseases such as rabies, Japanese encephalitis, cholera, and rotavirus. Additionally, BBIL is also involved in the development of vaccines for COVID-19, and has collaborated with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) to develop Covaxin, a vaccine for the prevention of COVID-19.